These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39305571)

  • 1. Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling.
    Olsen MB; Louwe MC; Yang K; Øgaard J; Dahl TB; Gregersen I; Alfsnes K; Lauritzen KH; Murphy SL; Ahmed MS; Aukrust P; Vinge LE; Yndestad A; Holven KB; Halvorsen B; Fosshaug LE
    Biochem Biophys Res Commun; 2024 Nov; 733():150706. PubMed ID: 39305571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors.
    Rodrigues-Diez R; Ballesteros-Martinez C; Moreno-Carriles RM; Nistal F; Díaz Del Campo LS; Cachofeiro V; Dalli J; García-Redondo AB; Redondo JM; Salaices M; Briones AM
    Biomed Pharmacother; 2024 May; 174():116564. PubMed ID: 38608525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension.
    Díaz Del Campo LS; García-Redondo AB; Rodríguez C; Zaragoza C; Duro-Sánchez S; Palmas F; de Benito-Bueno A; Socuéllamos PG; Peraza DA; Rodrigues-Díez R; Valenzuela C; Dalli J; Salaices M; Briones AM
    Hypertension; 2023 Jan; 80(1):84-96. PubMed ID: 36337053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
    Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
    FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
    Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron PA; Sharma AK; Upchurch GR
    FASEB J; 2024 Sep; 38(18):e70067. PubMed ID: 39320982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension.
    Olivares-Silva F; De Gregorio N; Espitia-Corredor J; Espinoza C; Vivar R; Silva D; Osorio JM; Lavandero S; Peiró C; Sánchez-Ferrer C; Díaz-Araya G
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166241. PubMed ID: 34400298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
    Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
    Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
    Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
    Chan SL; Umesalma S; Baumbach GL
    Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
    Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
    Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
    J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway.
    Wei C; Zhang J; Peng S; Liu J; Xu Y; Zhao M; Xu S; Pan W; Yin Z; Zheng Z; Qin JJ; Wan J; Wang M
    J Hypertens; 2024 Mar; 42(3):420-431. PubMed ID: 37937508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
    Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
    FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness.
    Eberson LS; Sanchez PA; Majeed BA; Tawinwung S; Secomb TW; Larson DF
    PLoS One; 2015; 10(4):e0124013. PubMed ID: 25875748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle-specific TMEM16A expression protects against angiotensin II-induced cerebrovascular remodeling via suppressing extracellular matrix deposition.
    Zeng XL; Sun L; Zheng HQ; Wang GL; Du YH; Lv XF; Ma MM; Guan YY
    J Mol Cell Cardiol; 2019 Sep; 134():131-143. PubMed ID: 31301303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.
    Wang H; Martinez Yus M; Brady T; Choi R; Nandakumar K; Smith L; Jang R; Wodu BP; Almodiel JD; Stoddart L; Kim DH; Steppan J; Santhanam L
    Am J Physiol Heart Circ Physiol; 2024 Sep; 327(3):H642-H659. PubMed ID: 39028284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infused juice concentrate of Japanese plum Prunus mume attenuates inflammatory vascular remodeling in a mouse model of hypertension induced by angiotensin II.
    Okuno K; Torimoto K; Kuroda R; Cicalese SM; Okuno Y; Kono R; Marumoto S; Utsunomiya H; Eguchi S
    Hypertens Res; 2023 Aug; 46(8):1923-1933. PubMed ID: 37308550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.